Cellular Reprogramming

杂志介绍

Cellular Reprogramming杂志介绍

《Cellular Reprogramming》是一本以English为主的未开放获取国际优秀期刊，中文名称细胞重编程，本刊主要出版、报道医学-BIOTECHNOLOGY & APPLIED MICROBIOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.2，最新CiteScore 指数为2.5。

本刊近期中国学者发表的论文主要有：

• Improves the In Vitro Developmental Competence and Reprogramming Efficiency of Cloned Bovine Embryos by Additional Complimentary Cytoplasm.

  Author: Xu L¹, Mesalam A^1,2, Lee KL¹, Song SH¹, Khan I¹, Chowdhury MMR^1,3, Lv W⁴, Kong IK^1,5.

• Rosuvastatin Regulates Odontoblast Differentiation by Suppressing NF-κB Activation in an Inflammatory Environment.

  Author: Feng X¹, Wang C¹, Gu Z², Ni J³, Huang D¹, Feng G¹, Lian M¹, Lu Q⁴, Song Y¹.

• The Role of 5-aza-2'-Deoxycytidine on Methylation Status of Xist Gene in Different Genders of Buffalo (Bubalus bubalis) Bone Marrow Mesenchymal Stem Cells.

  Author: Zhao X¹, Ruan Z¹, Qin X¹, Feng Y¹, Yu Q¹, Xu J¹, Deng Y¹, Shen P¹, Shi D¹, Lu F¹.

• Rosuvastatin Alleviates Ischemia/Reperfusion Injury in Cardiomyocytes by Downregulating Hsa-miR-24-3p to Target Upregulated Uncoupling Protein 2.

  Author: Wei W¹, Peng J¹, Shen T².

英文介绍

Cellular Reprogramming杂志英文介绍

Cellular Reprogramming is the premier journal dedicated to providing new insights on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms. The Journal delivers information on cutting-edge techniques and the latest high-quality research and discoveries that are transforming biomedical research.

Cellular Reprogramming coverage includes:

Somatic cell nuclear transfer and reprogramming in early embryos

Embryonic stem cells

Nuclear transfer stem cells (stem cells derived from nuclear transfer embryos)

Generation of induced pluripotent stem (iPS) cells and/or potential for cell-based therapies

Epigenetics

Adult stem cells and pluripotency.